Deferred Tax Assets, Valuation Allowance of NovaBridge Biosciences from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NovaBridge Biosciences quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • NovaBridge Biosciences Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $56,015,000, a 42% increase year-over-year.
NovaBridge Biosciences quarterly Deferred Tax Assets, Valuation Allowance in CNY history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • NovaBridge Biosciences Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2023 was ¥1,191,114,000, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)
Deferred Tax Assets, Valuation Allowance, Quarterly (CNY)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

NovaBridge Biosciences Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $56,015,000 +$16,512,000 +42% 31 Dec 2024 20-F 03 Apr 2025 2024 FY
Q4 2023 $39,503,000 +$888,000 +2.3% 31 Dec 2023 20-F 03 Apr 2025 2024 FY
Q4 2022 $38,615,000 +$15,514,000 +67% 31 Dec 2022 20-F 03 Apr 2025 2024 FY
Q4 2021 $23,101,000 +$7,377,000 +47% 31 Dec 2021 20-F 03 Apr 2025 2024 FY
Q4 2020 $15,724,000 -$9,640,000 -38% 31 Dec 2020 20-F 29 Apr 2022 2021 FY
Q4 2019 $25,364,000 +$11,788,000 +87% 31 Dec 2019 20-F 28 Apr 2021 2020 FY
Q4 2018 $13,576,000 31 Dec 2018 20-F 29 Apr 2020 2019 FY

NovaBridge Biosciences Quarterly Deferred Tax Assets, Valuation Allowance (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 ¥1,191,114,000 +¥218,996,000 +23% 31 Dec 2023 20-F 30 Apr 2024 2023 FY
Q4 2022 ¥972,118,000 +¥478,885,000 +97% 31 Dec 2022 20-F 30 Apr 2024 2023 FY
Q4 2021 ¥493,233,000 +¥393,029,000 +392% 31 Dec 2021 20-F 30 Apr 2024 2023 FY
Q4 2020 ¥100,204,000 -¥65,293,000 -39% 31 Dec 2020 20-F 30 Apr 2024 2023 FY
Q4 2019 ¥165,497,000 +¥70,986,000 +75% 31 Dec 2019 20-F 01 May 2023 2022 FY
Q4 2018 ¥94,511,000 +¥44,970,000 +91% 31 Dec 2018 20-F 29 Apr 2022 2021 FY
Q4 2017 ¥49,541,000 +¥43,069,000 +665% 31 Dec 2017 20-F 28 Apr 2021 2020 FY
Q4 2016 ¥6,472,000 31 Dec 2016 20-F 29 Apr 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.